Drug Trial Radar · NCT06665100
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
Last checked: Nov 19, 2026Latest source record: Aug 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Jun 27, 2025
Primary completion
Apr 2027
Study completion May 2027
Sponsor
- Lead sponsor
- Pulmotect, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Cancer Prevention Research Institute of Texas
- First posted
- Oct 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this research study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity of lung infections in patients with hematologic malignancies and recipients of hematopoietic stem cell transplantation with documented viral infections due to PIV, hMPV, or RSV. PUL-042 or a placebo will be administered 3 times over a 6-day period. The total duration of the study will be approximately 30 days.
Conditions
- Hematologic Malignancies
- Hematopoietic Stem Cell Transplant (HSCT)
Interventions
PUL-042Drug
Pam2 : ODN (PUL-042) PUL-042 Inhalation Solution
PlaceboDrug
Sterile Saline for Inhalation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy of PUL-042 Inhalation Solution on Lower Respiratory Tract Complications (LRTC)Time frame: 28 days
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
City of Hope National Medical Center
Duarte, California · Recruiting
Northside Hospital
Atlanta, Georgia · Recruiting
Johns Hopkins Hospital
Baltimore, Maryland · Recruiting
Brigham and Women's Hospital
Boston, Massachusetts · Recruiting
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan · Recruiting
University of Minnesota
Minneapolis, Minnesota · Recruiting
John Theurer Cancer Center
Hackensack, New Jersey · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Active not recruiting
Lineberger Cancer
Chapel Hill, North Carolina · Recruiting
OU Health Physicians - Infectious Disease Clinic
Oklahoma City, Oklahoma · Recruiting
University of Texas MD Anderson MD Anderson Cancer Center
Houston, Texas · Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.